Telomere DNA damage promotes mammary gland fibrosis and estrogen receptor-positive breast cancer

被引：0
|
作者：
Wu, Jianchun
Crowe, David L.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4778
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4778
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
  • [22] Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
    Datta, Jharna
    Willingham, Natalie
    Manouchehri, Jasmine M.
    Schnell, Patrick
    Sheth, Mirisha
    David, Joel J.
    Kassem, Mahmoud
    Wilson, Tyler A.
    Radomska, Hanna S.
    Coss, Christopher C.
    Bennett, Chad E.
    Ganju, Ramesh K.
    Sardesai, Sagar D.
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Stover, Daniel G.
    Cherian, Mathew A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene P.
    Wei, Shi
    HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
  • [24] Bicalutamide Plus Aromatase Inhibitor in Patients with Estrogen Receptor-Positive/Androgen Receptor-Positive Advanced Breast Cancer
    Lu, Qianyi
    Xia, Wen
    Lee, Kaping
    Zhang, Jingmin
    Yuan, Huimin
    Yuan, Zhongyu
    Shi, Yanxia
    Wang, Shusen
    Xu, Fei
    ONCOLOGIST, 2020, 25 (01): : 21 - +
  • [25] Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome
    Cody Plasterer
    Shirng-Wern Tsaih
    Amy R. Peck
    Inna Chervoneva
    Caitlin O’Meara
    Yunguang Sun
    Angela Lemke
    Dana Murphy
    Jennifer Smith
    Sophia Ran
    Albert J. Kovatich
    Jeffrey A. Hooke
    Craig D. Shriver
    Hai Hu
    Edith P. Mitchell
    Carmen Bergom
    Amit Joshi
    Paul Auer
    Jeremy Prokop
    Hallgeir Rui
    Michael J. Flister
    Breast Cancer Research and Treatment, 2019, 177 : 77 - 91
  • [26] Interferon Signaling in Estrogen Receptor-positive Breast Cancer: A Revitalized Topic
    Fu, Xiaoyong
    De Angelis, Carmine
    Schiff, Rachel
    ENDOCRINOLOGY, 2022, 163 (01)
  • [27] Tannic Acid Preferentially Targets Estrogen Receptor-Positive Breast Cancer
    Booth, Brian W.
    Inskeep, Beau D.
    Shah, Hiral
    Park, Jang Pyo
    Hay, Elizabeth J.
    Burg, Karen J. L.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [28] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 249 - 252
  • [29] Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
    Ao, Ada
    Morrison, Brian J.
    Wang, Heiman
    Lopez, J. Alejandro
    Reynolds, Brent A.
    Lu, Jianrong
    PLOS ONE, 2011, 6 (04):
  • [30] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2017, 28 : 27 - 27
12345